Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Osteoporosis in Post-menopausal Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01674621
What this trial is testing

Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis

Who this might be right for
Post Menopausal Osteoporosis
Radius Health, Inc. 250
Post-approval studies (Phase 4)Study completedNCT00551174
What this trial is testing

Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment

Who this might be right for
Post-Menopausal Osteoporosis
Hoffmann-La Roche 781
Large-scale testing (Phase 3)Study completedNCT00048074
What this trial is testing

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 1,395
Large-scale testing (Phase 3)Study completedNCT00310531
What this trial is testing

3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women

Who this might be right for
Osteopenia
Bayer 500
Post-approval studies (Phase 4)Study completedNCT00545051
What this trial is testing

Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.

Who this might be right for
Postmenopausal Osteoporosis
Hoffmann-La Roche 140
Large-scale testing (Phase 3)Study completedNCT01290094
What this trial is testing

Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 41
Large-scale testing (Phase 3)Study completedNCT03432533
What this trial is testing

A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis

Who this might be right for
Post-Menopausal Osteoporosis
Amgen 283
Large-scale testing (Phase 3)Study completedNCT00420940
What this trial is testing

The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause

Who this might be right for
Bone DensityOsteopeniaOsteoporosis+1 more
University Health Network, Toronto 202
Post-approval studies (Phase 4)Study completedNCT00545363
What this trial is testing

Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)

Who this might be right for
Postmenopausal Osteoporosis
Hoffmann-La Roche 716
Not applicableStudy completedNCT00399321
What this trial is testing

A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Who this might be right for
Postmenopausal Bone LossBreast Cancer
University of Michigan Rogel Cancer Center 9
Large-scale testing (Phase 3)Study completedNCT00545779
What this trial is testing

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.

Who this might be right for
Post-Menopausal Osteoporosis
Hoffmann-La Roche 677
Post-approval studies (Phase 4)Study completedNCT00303485
What this trial is testing

Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 67
Post-approval studies (Phase 4)Not Yet RecruitingNCT06720350
What this trial is testing

Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures

Who this might be right for
Osteoporosis in Post-menopausal Women
Marmara University 60
Early research (Phase 1)UnknownNCT03242512
What this trial is testing

Assessment of Anti-RANKL Antibody in Post-menopausal Women

Who this might be right for
Osteoporosis
Jiangsu T-Mab Biopharma Co.,Ltd 24
Post-approval studies (Phase 4)Study completedNCT00532545
What this trial is testing

Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis, Post-Menopausal
Eli Lilly and Company 45
Not applicableStudy completedNCT00787904
What this trial is testing

Role of T-cells in Post-Menopausal Osteoporosis

Who this might be right for
Osteoporosis
Atlanta VA Medical Center 19
Not applicableStudy completedNCT01381588
What this trial is testing

The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
GlaxoSmithKline 1,136
Not applicableNot Yet RecruitingNCT06835413
What this trial is testing

Monitoring Combined Effect of Balance and Strengthening Exercises on Static and Dynamic Balance in Elderly Populations

Who this might be right for
Geriatrics Balance Disturbance With High Risk Falling, Osteoporosis, Vestibular Age Related Changes, Female Post-menopausal Based on History
South Valley University 60
Large-scale testing (Phase 3)UnknownNCT05419427
What this trial is testing

Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Lambda Therapeutic Research Ltd. 552
Testing effectiveness (Phase 2)Study completedNCT00293813
What this trial is testing

A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density

Who this might be right for
Postmenopausal Osteoporosis
Amgen 247
Next Page